Tagamet treat histamine,Cimetidine generic
Home       Treatment        Side Effects       GlaxoSmithKline       FDA Aproval

 

Introduction to the Cimetidine – Tagamet
What is Cimetidine – Tagamet?
Cimetidine is a histamine H2-receptor antagonist that inhibits the production of acid in the stomach. It is largely used in the treatment of heartburn and peptic ulcers. Cimetidine is marketed by GlaxoSmithKline under the brand name Tagamet. The drug was approved by the Food & Drug Administration for prescription since January 1979. Sometimes Tagamet is marketed under Tagamet HB or Tagamet HB200.

Generic Name: Cimetidine
Brand Name: Tagamet

 
Cimetidine was the prototypical histamine H2-receptor antagonist from which the later members of the class were developed. Cimetidine was the culmination of a project at Smith, Kline & French. This was one of the first drugs discovered using a rational drug design approach. t the time (1964) it was known that histamine was able to stimulate the secretion of stomach acid. In the process, the scientists also proved the existence of histamine H2-receptors in Tagamet. GlaxoSmithKline has setup several factories, units all across America in manufacturing, distributing the drug.

Buy Cimetidine – Tagamet
Anyone can buy Tagamet from medical stores with the doctor's prescription. The drug is even purchased from various medical websites. It is readily available in the market which can be ordered by various other means.

Availability of Cimetidine – Tagamet
Cimetidine or the Tagamet are available through out the world but prominently available in countries like US, UK, Canada and Australia.

Dose for Cimetidine – Tagamet
Cimetidine is usually prescribed once in a day by injecting the drug. This drug dose ranges depending on the patients physical strength. It can be taken with or without meals. The treatment is given only for few weeks or months.

Enquiry Field Marked with asterisk (*) are mandatory
Name * Email *
State/Country
Comments *
 
 

 

 
Home       Treatment        Side Effects       GlaxoSmithKline       FDA Aproval